Read today’s Kaiser Health News
In other news:
About pharma
Genmab to Buy Cancer-Treatment Developer Merus For $8 Billion in Cash: Danish biotechnology company Genmab agreed to buy Nasdaq-listed cancer-treatment developer Merus for around $8 billion in cash, as it looks to bolster its late-stage pipeline as part of a shift toward commercializing more drugs in-house.
Pfizer to lower US drug prices; White House unveils ‘TrumpRx’ site: Pfizer has become the first drugmaker to lower the price of its prescription medications in the U.S. through a new deal with the federal government, President Donald Trump announced during a Sept. 30 media briefing.
The White House is also launching a direct-to-consumer website for prescription medications, which will carry the discounted drugs.